KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer

Liu, XH; Qiu, RF; Xu, M; Meng, MM; Zhao, SY; Ji, JS; Yang, Y

Ji, JS; Yang, Y (corresponding author), Zhejiang Univ, Lishui Hosp, Sch Med, Zhejiang Prov Key Lab Imaging Diag & Minimally In, Lishui 323000, Zhejiang, Peoples R China.; Ji, JS; Yang, Y (corresponding author), Wenzhou Med Univ, Affiliated Hosp 5, Dept Radiol, Lishui 323000, Peoples R China.; Yang, Y (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin 300070, Peoples R China.

BREAST CANCER RESEARCH AND TREATMENT, 2021; 189 (2): 347

Abstract

Purpose Epigenetic regulation plays critical roles in cancer progression, and high-frequency mutations or expression variations in epigenetic regulato......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索